Michael W. Russell

Michael W. Russell is an internationally-recognized expert and leader in mucosal immunity to infections of the mouth and genital tract. He joined Therapyx, Inc. as CSO in 2018. He is also Emeritus Professor of Microbiology & Immunology at SUNY/Buffalo. His laboratory developed novel approaches for inducing protective immunity to genital tract infections, especially by Neisseria gonorrhoeae, based on understanding of the manner in which these organisms exploit and manipulate the host’s immune system. Dr. Russell oversees the scientific programs of the Company with specific focus on infectious disease therapeutics including GneX12TM and NGoXIM™.